科隆股份(300405) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥148,531,576.33, a decrease of 14.85% compared to ¥174,436,566.68 in the same period last year[4] - The net loss attributable to shareholders was ¥5,969,724.87, representing a 183.43% increase in losses from ¥2,106,220.06 year-on-year[4] - Basic and diluted earnings per share were both -¥0.0206, reflecting a decline of 182.19% from -¥0.0073 in the same quarter last year[4] - Total operating revenue for Q1 2023 was CNY 148,622,174.15, a decrease of 15% compared to CNY 174,760,375.49 in the same period last year[17] - The company's net loss for Q1 2023 was CNY 10,127,880.83, compared to a net loss of CNY 2,886,211.36 in Q1 2022, indicating a worsening of financial performance[17] - The net profit for Q1 2023 was -6,027,318.36 CNY, compared to -1,297,188.74 CNY in Q1 2022, representing an increase in net loss of approximately 365.5%[19] - The operating profit for Q1 2023 was -5,234,099.69 CNY, a decline from -1,013,878.97 CNY in the same period last year, indicating a worsening performance[19] - The total comprehensive income for Q1 2023 was -6,027,318.36 CNY, compared to -1,297,188.74 CNY in Q1 2022, showing a significant deterioration in overall financial health[19] Cash Flow and Assets - The net cash flow from operating activities improved to -¥10,660,528.61, a significant increase of 82.86% compared to -¥62,206,509.59 in the previous year[4] - Cash and cash equivalents at the end of Q1 2023 were CNY 210,601,008.23, slightly down from CNY 212,272,931.90 at the beginning of the year[13] - Total cash and cash equivalents at the end of Q1 2023 were 113,992,913.45 CNY, down from 141,845,423.80 CNY at the end of Q1 2022[22] - The total assets of the company as of March 31, 2023, were CNY 1,467,614,058.76, down from CNY 1,477,207,507.72 at the beginning of the year[15] - Total liabilities decreased to CNY 822,072,726.54 from CNY 825,646,907.29, a reduction of about 0.3%[16] - The company's equity attributable to shareholders was CNY 633,330,456.69, down from CNY 639,292,131.41, indicating a decrease of approximately 0.9%[16] Research and Development - The company reported a 59.92% decrease in R&D expenses, totaling ¥1,541,214.62 compared to ¥3,845,754.71 in Q1 2022[6] - Research and development expenses for Q1 2023 were CNY 1,541,214.62, significantly lower than CNY 3,845,754.71 in the previous year, reflecting a reduction of about 60%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period is 13,150[8] - The largest shareholder, Jiang Yan, holds 29.58% of the shares, totaling 85,550,854 shares[8] - The company has a total of 70,382,793 restricted shares at the end of the reporting period, with 1 share released during the period[10] - The top 10 shareholders account for a significant portion of the company's equity, with Jiang Yan alone holding nearly 30%[8] - The company has not disclosed any information regarding the participation of top shareholders in margin trading[8] - The company has a total of 64,163,140 shares under management lock-up for Jiang Yan, with a release schedule based on regulatory requirements[10] - The company has not reported any changes in the number of preferred shareholders or their holdings[9] Operational Changes - The company plans to suspend production for approximately 60 days starting March 28, 2023, due to maintenance by a key supplier[12] - The company is currently undergoing a production line maintenance process, which will be aligned with the supplier's maintenance schedule[12] Other Financial Metrics - The company experienced a 157.48% increase in contract liabilities, reaching ¥32,400,244.46 due to an increase in advance payments received[6] - The company recorded a 240.41% increase in credit impairment losses, amounting to ¥3,650,245.61, attributed to higher receivables impairment losses[6] - The company received government subsidies amounting to ¥1,309,722.94, which are closely related to its normal business operations[5] - The company reported a significant increase in other operating income, which rose by 200.62% to ¥70,018.49 due to compensation received during the reporting period[6] - The company incurred credit impairment losses of 3,650,245.61 CNY in Q1 2023, compared to 1,072,305.89 CNY in the same period last year, indicating increased financial strain[19]